Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)
NCT01546116
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
ADEFOVIR, LAMIVUDINE
Sponsor
Korea University
Collaborators
[object Object]